Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors

Author： Millan Mark   Iob Loretta   Péglion Jean-Louis   Dekeyne Anne  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.191, Iss.3, 2007-04, pp. : 767-782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats

By Millan Mark   Seguin Laetitia   Gobert Alain   Cussac Didier   Brocco Mauricette  

Psychopharmacology, Vol. 174, Iss. 3, 2004-07 ,pp. : 341-357

Springer Publishing Company

Access to resources Recommend Favorite

Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA

By Bubar Marcy   Pack Kami   Frankel Paul   Cunningham Kathryn  

Psychopharmacology, Vol. 173, Iss. 3-4, 2004-05 ,pp. : 326-336

Springer Publishing Company

Access to resources Recommend Favorite

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3700-3724

Bentham Science Publishers

Access to resources Recommend Favorite

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

By Keck Jr Paul E   McElroy Susan L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 655-662

Informa Healthcare

Access to resources Recommend Favorite

Antidepressant drugs given repeatedly change the binding of the dopamine D 2 receptor agonist, [ 3 H]N-0437, to dopamine D 2 receptors in the rat brain

By Maj J.   Dziedzicka-Wasylewska M.   Rogoz R.   Rogoz Z.   Skuza G.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 49-54

Elsevier

Access to resources Recommend Favorite